Unaudited financial results for quarter ended June 30, 2026.

August 11, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub: Outcome of Board Meeting and Unaudited Financial Results – pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’). We write to inform you that the Board of Directors of the Company, at its meeting held on August 11, 2026, has, inter alia, approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. We are also enclosing herewith the Limited Review Reports on the aforesaid results (Standalone and Consolidated) issued by M/s. SRBC & Co. LLP, Chartered Accountants, Statutory Auditors of the Company with an unmodified opinion on the above-mentioned financial results dated August 11, 2026. Kindly take the above on record. The Board meeting commenced at 11:00 a.m. (IST) and concluded at 01:10 p.m. (IST). Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861 Encl: As above